Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07398443 · ClinicalTrials.gov registry record · NA
Using Novel Behavioral Economic Measures to Characterize Dual Marijuana and Tobacco Use in Young Adults
A NA study of Tobacco Smoking and Cannabis Smoking, sponsored by Brown University.
- Recruiting
- Registry status
- NA
- Development phase
- 120
- Enrollment target
- 1
- Study location
NCT07398443: Recruiting NA study of Tobacco Smoking and Cannabis Smoking, sponsored by Brown University.
NCT07398443 is a NA study of Tobacco Smoking and Cannabis Smoking that is actively recruiting participants, run by Brown University. The registered enrollment target is 120 participants, below the 474-participant average among 38 other Tobacco Smoking trials with a reported enrollment target (75% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07398443, a NA study of Tobacco Smoking and Cannabis Smoking, is actively recruiting participants, sponsored by Brown University.
- RECRUITING
- Registry status
- NA
- Development phase
- 120 participants
- Enrollment target
- 1
- Study location
Study Summary
The multi session experimental study aims to determine dual use patterns of marijuana and tobacco by assessing the impact of price and availability of marijuana and tobacco using a cross price elasticity of demand task. The study will recruit 120 non-treatment seeking emerging young adults (18-25 years) who smoke marijuana and tobacco.
Primary Outcome
This study utilizes a structured cannabis cue exposure paradigm. During cue exposure, participants rate subjective craving on a scale from 0, "Not at all," to 10, "Extremely." Cannabis craving will be assessed following neutral cue exposure and then cannabis cue exposure. The primary outcome will be change in cannabis craving.
Conditions Studied
Interventions
- BEHAVIORAL Cue Reactivity
Study Locations (1)
Rhode Island
- Brown University School of Public Health - Providence
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 120 participants |
| Start Date | 2026-02-17 |
| Est. Completion | 2028-11-30 |
| Phase | NA |
What NCT07398443 shows while recruiting
NCT07398443 is an interventional study that assigns participants to a tested intervention. The registered 120 participants enrollment target is mid-sized for trials with a published cap, below the 474-participant average among 38 other Tobacco Smoking trials with a reported enrollment target (75% lower).
The record links to 3 conditions, with Tobacco Smoking appearing as the primary indexed condition, and to 1 intervention - of which Cue Reactivity is the first listed.
NCT07398443 reports a single indexed study location in Rhode Island.
Frequently Asked Questions
What is clinical trial NCT07398443 about?
NCT07398443 is a clinical study titled "Using Novel Behavioral Economic Measures to Characterize Dual Marijuana and Tobacco Use in Young Adults". The multi session experimental study aims to determine dual use patterns of marijuana and tobacco by assessing the impact of price and availability of marijuana and tobacco using a cross price elasticity of demand task. The study will recruit 120 non-treatment seeking emerging young adults (18-25 ye...
What is the current status of trial NCT07398443?
This trial is currently recruiting. It is a NA study. The enrollment target is 120 participants. The study started on 2026-02-17. Estimated completion is 2028-11-30.
What conditions does trial NCT07398443 study?
This clinical trial studies the following conditions: Tobacco Smoking, Cannabis Smoking, Behavioral Economics.
What interventions are being tested in trial NCT07398443?
The interventions under investigation include: Cue Reactivity (BEHAVIORAL).
Who is sponsoring clinical trial NCT07398443?
This trial is sponsored by Brown University, which has 231 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT07398443 being conducted?
This trial has 1 study location across Rhode Island. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Tobacco Smoking
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT07398443's enrollment target sits among peer trials
120 15th of 38 higher than 22 of 38 other Tobacco Smoking trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Tobacco Smoking trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Reach Through Equitable Implementation in Utah
RECRUITING · NA
-
Development of a Smoking Cessation Video Series
RECRUITING · NA
-
Trauma-Informed Care for Smoking Cessation for Pregnancy
RECRUITING · NA
-
A Study Evaluating the Use of an Indoor Air Quality Monitor to Promote a Smoke-free Home
RECRUITING · NA
-
CONNECT Cancer Survivors With Tobacco Treatment
RECRUITING · NA
-
Abuse Liability for Five Modern Oral Nicotine Products
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01174108 · 120 participants · Phase 2
Allogeneic Hematopoietic Stem Cell Transplantation for Severe Aplastic Anemia and Other Bone Marrow Failure Syndromes Using G-CSF Mobilized CD34+ Selected Hematopoietic Precursor Cells Co-Infused With a Reduced Dose of Non-Mobilized Donor T-cells
- NCT01627301 · 120 participants · NA
Sympathetic Overactivity in Post-traumatic Stress Disorder
- NCT02025023 · 120 participants · Phase 3
Local 5-Fluorouracil Injection for the Treatment of Chalazia: A Prospective, Comparative Study
- NCT02128906 · 120 participants · Phase 2
Radiotherapy With Cisplatin vs. Docetaxel-cetuximab in HNSCC: ERCC1 Biomarker Enrichment and Interaction Design
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI